Skip to main content

Table 6 Pre-specified indicators of guideline-concordant investigation

From: Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment

 

RIC (%)

Non-RIC (%)

p-valuea

PET scans in stage I/II NSCLC

48/51 (94)

45/ 55(82)

0.05a

Brain imaging in stage IIIA NSCLC

26/ 51(51)

14/ 37(38)

0.22a

Brain imaging in SCLC

24/26 (92)

5/7 (72)

0.13b

Patient seen in multi-disciplinary lung cancer clinic, or case reviewed at Tumor Board

144/ 195 (74)

73/132 (55)

<0.01a

  1. Chi-squareda or Fisher’s exact testb were used